These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15892503

  • 21. Current management of diabetes mellitus and future directions in care.
    Chatterjee S, Davies MJ.
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [Abstract] [Full Text] [Related]

  • 22. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
    Saha SA, Tuttle KR.
    Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
    [Abstract] [Full Text] [Related]

  • 23. [A therapeutic option for type-2 diabetes. The incretion hormone GLP-1].
    Göke B, Hoppe B, Konrad A, Schirra J.
    Pharm Unserer Zeit; 2002 Aug; 31(3):294-9. PubMed ID: 12071126
    [No Abstract] [Full Text] [Related]

  • 24. Oral pharmacologic management of type 2 diabetes.
    Riddle MC.
    Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
    [Abstract] [Full Text] [Related]

  • 25. Oral combination therapy in primary care.
    Kalra S, Gupta Y.
    J Pak Med Assoc; 2015 May; 65(5):574-5. PubMed ID: 26028398
    [Abstract] [Full Text] [Related]

  • 26. Diabetes and diabetes medications.
    Turkoski BB.
    Orthop Nurs; 2006 May; 25(3):227-31. PubMed ID: 16735857
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes.
    Nauck M.
    Diabet Med; 1996 Sep; 13(9 Suppl 5):S39-43. PubMed ID: 8894470
    [Abstract] [Full Text] [Related]

  • 28. [Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?].
    Matthes J, Faust M.
    Dtsch Med Wochenschr; 2008 Oct; 133(43):2233-7. PubMed ID: 18924057
    [No Abstract] [Full Text] [Related]

  • 29. Theratechnologies expands peptide portfolio in endocrinology.
    Walczak IM.
    Diabetes Technol Ther; 2002 Oct; 4(5):734. PubMed ID: 12458565
    [No Abstract] [Full Text] [Related]

  • 30. Effect of vildagliptin on glucagon concentration during meals in patients with type 1 diabetes.
    Foley JE, Ligueros-Saylan M, He YL, Holst JJ, Deacon CF, Dunning BE, Leone-Jones A, Yu T, Kelley DE.
    Horm Metab Res; 2008 Oct; 40(10):727-30. PubMed ID: 18597213
    [No Abstract] [Full Text] [Related]

  • 31. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF, Edwards CM, Ghatei MA, Mather HM, Bloom SR.
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [Abstract] [Full Text] [Related]

  • 32. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
    Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
    [No Abstract] [Full Text] [Related]

  • 33. [Selection of oral antidiabetic drugs].
    Iwamoto Y.
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():428-32. PubMed ID: 15779417
    [No Abstract] [Full Text] [Related]

  • 34. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
    Göke R, Gruenberger JB, Bader G, Dworak M.
    Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429
    [Abstract] [Full Text] [Related]

  • 35. Molecule of the month. Vildagilptin.
    Drug News Perspect; 2006 May; 19(4):228. PubMed ID: 16823497
    [No Abstract] [Full Text] [Related]

  • 36. Insulin and oral hypoglycemic agents.
    Price MJ.
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacologic management of diabetes mellitus.
    Mozersky RP.
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA.
    Horm Metab Res; 2004 Dec; 36(11-12):852-8. PubMed ID: 15655719
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.